| Mepha Pharma AG - Co-Amoxi-Mepha 625 Dispersible, dispergierbare Tabletten | | 57338 | | 01 | | Co-Amoxi-Mepha 625 Dispersible | | dispergierbare Tabletten | | J01CR02 | | Amoxicillin and Beta-Lactamase Inhibitor | | 01.02.2007 | | |
| | Composition | | amoxicillinum anhydricum 500 mg ut amoxicillinum trihydricum, acidum clavulanicum 125 mg ut kalii clavulanas, crospovidonum, silica colloidalis hydrica, sucralosum, aromatica (Orange), E 172 (flavum), magnesii stearas, cellulosum microcristallinum silicificatum, pro compresso. | | Packungsbestandteile | | Dispersible Tablets | | | | | Active Agent | Dose |
|---|
| Clavulanic Acid | 125 mg | | Amoxicillin Anhydride | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Clavulanic Acid | 125 mg | | Amoxicillin Anhydride | 500 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Flavum) | | | | Aromatica (Orange) | | | | Cellulosum Microcristallinum Silicificatum | | | | Crospovidonum | | | | E 172 | | color. | | Magnesii Stearas | | | | Pro Compresso | | | | Silica Colloidalis Hydrica | | | | Sucralosum | | |
| |
| |
|
